3.1.4.39	0.0000061	-	cyclohexanaminium hydrogen [[4-(decanoylamino)phenyl](fluoro)methyl]phosphonate	pH and temperature not specified in the publication	714443	
3.1.4.39	0.000009	-	cyclohexanaminium hydrogen [4-(tetradecanoylamino)benzyl]phosphonate	pH and temperature not specified in the publication	714443	
3.1.4.39	0.00001	-	PF8380	pH and temperature not specified in the publication	729701	
3.1.4.39	0.000018	-	cyclohexanaminium hydrogen [4-(decanoylamino)benzyl]phosphonate	pH and temperature not specified in the publication	714443	
3.1.4.39	0.000024	-	cyclohexanaminium hydrogen [[4-(decanoylamino)phenyl](hydroxy)methyl]phosphonate	pH and temperature not specified in the publication	714443	
3.1.4.39	0.0000242	-	cyclohexanaminium hydrogen [[4-(decanoylamino)phenyl](hydroxy)methyl]phosphonate	pH and temperature not specified in the publication	714443	
3.1.4.39	0.000072	-	cyclohexanaminium hydrogen [[4-(decanoylamino)phenyl](fluoro)methyl]phosphonate	pH and temperature not specified in the publication	714443	
3.1.4.39	0.0001	-	1-acyl glycerol 3-phosphate	CPF4 FRET assay (change of fluorescence intensity), inihibition involves both a reduction in vmax and an increase in km, binding affinity is 1000fold stronger than to 1-alkyl-sn-glycero-3-phosphoethanolamine and analogue substrates	697490	
3.1.4.39	0.00011	-	lysophosphatidic acid	-	665628	
3.1.4.39	0.0002	-	2-amino-2-(2-(4-octylphenyl) ethyl)propan-1,3-diol	substrate p-nitrophenyl thymidine 5-monophosphate, pH 8.0, 30 min of incubation at 37°C, measuring absorbance at 405 nm, twofold higher KI compared to inhibitor S1P	697080